Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-3476(78)80199-1DOI Listing

Publication Analysis

Top Keywords

veno-occlusive familial
4
familial hepatic
4
hepatic disease
4
veno-occlusive
1
hepatic
1
disease
1

Similar Publications

Article Synopsis
  • - Veno-occlusive disease with immunodeficiency (VODI) syndrome is a rare genetic disorder with immune system issues and high mortality, linked to mutations on chromosome 2q37.1, particularly concerning tuberculosis.
  • - A case study of a three-year-old girl with suspected immunodeficiency utilized whole-exome sequencing (WES) to find and confirm pathogenic mutations, revealing a novel deletion-insertion mutation affecting the SP110 protein.
  • - This research aims to improve the diagnosis of VODI syndrome by identifying various mutations in the SP110 gene, which could lead to targeted therapies and better treatment options.
View Article and Find Full Text PDF

Despite its rarity, pulmonary capillary hemangiomatosis (PCH) presents a significant diagnostic challenge. Due to its similarity to other pulmonary vascular diseases, such as pulmonary veno-occlusive disease, it is characterized by abnormal pulmonary capillary proliferation, which is a rare cause of primary pulmonary hypertension. This case was the first reported instance of PCH in Shahid Rajaee Heart Hospital in Tehran, Iran, in 2023, which was confirmed by genetic testing.

View Article and Find Full Text PDF

Objective: To report the outcomes of pediatric patients who underwent allogeneic hematopoietic stem cell transplant (HSCT) in single rooms without high-efficiency particulate air (HEPA) filters, laminar air flow or positive pressure at our centre and discuss the adaptations of a high-volume government centre.

Methods: Data of the first 20 children who underwent allogeneic HSCT between May 2019 and July 2023 in adaptive settings were reviewed retrospectively. All patients were managed in in single rooms without HEPA filters, positive pressure or laminar air flow.

View Article and Find Full Text PDF

Functional validation of EIF2AK4 (GCN2) missense variants associated with pulmonary arterial hypertension.

Hum Mol Genet

August 2024

Cambridge Institute for Medical Research (CIMR), University of Cambridge, Keith Peters Building, Biomedical Campus, Hills Rd, Cambridge CB2 0XY, United Kingdom.

Article Synopsis
  • Pulmonary arterial hypertension (PAH) is linked to genetic factors, particularly mutations in the EIF2AK4 gene, which can lead to rare subtypes like pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis.
  • Some EIF2AK4 variants found in classical PAH patients have uncertain significance, prompting a need for further study to understand their impact on the disease.
  • Researchers applied both computational and experimental methods to assess sixteen EIF2AK4 variants, discovering that many did not impair kinase function and classifying dysfunctional variants into groups that could potentially be targeted for treatment with specific inhibitors.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!